Can Certain Genotypes Predispose to Poor Asthma Control in Children? A Pharmacogenetic Study of 9 Candidate Genes in Children with Difficult Asthma. e60592

Objective We tested the hypothesis that patients with difficult asthma have an increased frequency of certain genotypes that predispose them to asthma exacerbations and poor asthma control. Methods A total of 180 Caucasian children with confirmed asthma diagnosis were selected from two phenotypic gr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2013-04, Vol.8 (4)
Hauptverfasser: Almomani, Basima, Hawwa, Ahmed F, Millership, Jeffrey S, Heaney, Liam, Douglas, Isabella, McElnay, James C, Shields, Michael D
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective We tested the hypothesis that patients with difficult asthma have an increased frequency of certain genotypes that predispose them to asthma exacerbations and poor asthma control. Methods A total of 180 Caucasian children with confirmed asthma diagnosis were selected from two phenotypic groups; difficult (n = 112) versus mild/moderate asthma (n = 68) groups. All patients were screened for 19 polymorphisms in 9 candidate genes to evaluate their association with difficult asthma. Key Results The results indicated that LTA4H A-9188>G, TNF alpha G-308>A and IL-4R alpha A1727>G polymorphisms were significantly associated with the development of difficult asthma in paediatric patients (pC, IL-4R alpha T1570>C and IL-4R alpha A1727>G and CA haplotype of TNF alpha C-863>A and TNF alpha G-308>A polymorphisms) which were significantly associated with difficult asthma in children (p = 0.04 and p = 0.018, respectively). Conclusions and Clinical Relevance The study revealed multiple SNPs and haplotypes in LTA4H, TNF alpha and IL4-R alpha genes which constitute risk factors for the development of difficult asthma in children. Of particular interest is the LTA4H A-9188>G polymorphism which has been reported, for the first time, to have strong association with severe asthma in children. Our results suggest that screening for patients with this genetic marker could help characterise the heterogeneity of responses to leukotriene-modifying medications and, hence, facilitate targeting these therapies to the subset of patients who are most likely to gain benefit.
ISSN:1932-6203
DOI:10.1371/journal.pone.0060592